Cargando…
Imitating evolution’s tinkering by protein engineering reveals extension of human galectin-7 activity
Wild-type lectins have distinct types of modular design. As a step to explain the physiological importance of their special status, hypothesis-driven protein engineering is used to generate variants. Concerning adhesion/growth-regulatory galectins, non-covalently associated homodimers are commonly e...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460509/ https://www.ncbi.nlm.nih.gov/pubmed/34152508 http://dx.doi.org/10.1007/s00418-021-02004-w |
_version_ | 1784571770640007168 |
---|---|
author | Ludwig, Anna-Kristin Michalak, Malwina Gabba, Adele Kutzner, Tanja J. Beckwith, Donella M. FitzGerald, Forrest G. García Caballero, Gabriel Manning, Joachim C. Kriegsmann, Mark Kaltner, Herbert Murphy, Paul V. Cudic, Maré Kopitz, Jürgen Gabius, Hans-Joachim |
author_facet | Ludwig, Anna-Kristin Michalak, Malwina Gabba, Adele Kutzner, Tanja J. Beckwith, Donella M. FitzGerald, Forrest G. García Caballero, Gabriel Manning, Joachim C. Kriegsmann, Mark Kaltner, Herbert Murphy, Paul V. Cudic, Maré Kopitz, Jürgen Gabius, Hans-Joachim |
author_sort | Ludwig, Anna-Kristin |
collection | PubMed |
description | Wild-type lectins have distinct types of modular design. As a step to explain the physiological importance of their special status, hypothesis-driven protein engineering is used to generate variants. Concerning adhesion/growth-regulatory galectins, non-covalently associated homodimers are commonly encountered in vertebrates. The homodimeric galectin-7 (Gal-7) is a multifunctional context-dependent modulator. Since the possibility of conversion from the homodimer to hybrids with other galectin domains, i.e. from Gal-1 and Gal-3, has recently been discovered, we designed Gal-7-based constructs, i.e. stable (covalently linked) homo- and heterodimers. They were produced and purified by affinity chromatography, and the sugar-binding activity of each lectin unit proven by calorimetry. Inspection of profiles of binding of labeled galectins to an array-like platform with various cell types, i.e. sections of murine epididymis and jejunum, and impact on neuroblastoma cell proliferation revealed no major difference between natural and artificial (stable) homodimers. When analyzing heterodimers, acquisition of altered properties was seen. Remarkably, binding properties and activity as effector can depend on the order of arrangement of lectin domains (from N- to C-termini) and on the linker length. After dissociation of the homodimer, the Gal-7 domain can build new functionally active hybrids with other partners. This study provides a clear direction for research on defining the full range of Gal-7 functionality and offers the perspective of testing applications for engineered heterodimers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00418-021-02004-w. |
format | Online Article Text |
id | pubmed-8460509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-84605092021-09-24 Imitating evolution’s tinkering by protein engineering reveals extension of human galectin-7 activity Ludwig, Anna-Kristin Michalak, Malwina Gabba, Adele Kutzner, Tanja J. Beckwith, Donella M. FitzGerald, Forrest G. García Caballero, Gabriel Manning, Joachim C. Kriegsmann, Mark Kaltner, Herbert Murphy, Paul V. Cudic, Maré Kopitz, Jürgen Gabius, Hans-Joachim Histochem Cell Biol Original Paper Wild-type lectins have distinct types of modular design. As a step to explain the physiological importance of their special status, hypothesis-driven protein engineering is used to generate variants. Concerning adhesion/growth-regulatory galectins, non-covalently associated homodimers are commonly encountered in vertebrates. The homodimeric galectin-7 (Gal-7) is a multifunctional context-dependent modulator. Since the possibility of conversion from the homodimer to hybrids with other galectin domains, i.e. from Gal-1 and Gal-3, has recently been discovered, we designed Gal-7-based constructs, i.e. stable (covalently linked) homo- and heterodimers. They were produced and purified by affinity chromatography, and the sugar-binding activity of each lectin unit proven by calorimetry. Inspection of profiles of binding of labeled galectins to an array-like platform with various cell types, i.e. sections of murine epididymis and jejunum, and impact on neuroblastoma cell proliferation revealed no major difference between natural and artificial (stable) homodimers. When analyzing heterodimers, acquisition of altered properties was seen. Remarkably, binding properties and activity as effector can depend on the order of arrangement of lectin domains (from N- to C-termini) and on the linker length. After dissociation of the homodimer, the Gal-7 domain can build new functionally active hybrids with other partners. This study provides a clear direction for research on defining the full range of Gal-7 functionality and offers the perspective of testing applications for engineered heterodimers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00418-021-02004-w. Springer Berlin Heidelberg 2021-06-21 2021 /pmc/articles/PMC8460509/ /pubmed/34152508 http://dx.doi.org/10.1007/s00418-021-02004-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Ludwig, Anna-Kristin Michalak, Malwina Gabba, Adele Kutzner, Tanja J. Beckwith, Donella M. FitzGerald, Forrest G. García Caballero, Gabriel Manning, Joachim C. Kriegsmann, Mark Kaltner, Herbert Murphy, Paul V. Cudic, Maré Kopitz, Jürgen Gabius, Hans-Joachim Imitating evolution’s tinkering by protein engineering reveals extension of human galectin-7 activity |
title | Imitating evolution’s tinkering by protein engineering reveals extension of human galectin-7 activity |
title_full | Imitating evolution’s tinkering by protein engineering reveals extension of human galectin-7 activity |
title_fullStr | Imitating evolution’s tinkering by protein engineering reveals extension of human galectin-7 activity |
title_full_unstemmed | Imitating evolution’s tinkering by protein engineering reveals extension of human galectin-7 activity |
title_short | Imitating evolution’s tinkering by protein engineering reveals extension of human galectin-7 activity |
title_sort | imitating evolution’s tinkering by protein engineering reveals extension of human galectin-7 activity |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460509/ https://www.ncbi.nlm.nih.gov/pubmed/34152508 http://dx.doi.org/10.1007/s00418-021-02004-w |
work_keys_str_mv | AT ludwigannakristin imitatingevolutionstinkeringbyproteinengineeringrevealsextensionofhumangalectin7activity AT michalakmalwina imitatingevolutionstinkeringbyproteinengineeringrevealsextensionofhumangalectin7activity AT gabbaadele imitatingevolutionstinkeringbyproteinengineeringrevealsextensionofhumangalectin7activity AT kutznertanjaj imitatingevolutionstinkeringbyproteinengineeringrevealsextensionofhumangalectin7activity AT beckwithdonellam imitatingevolutionstinkeringbyproteinengineeringrevealsextensionofhumangalectin7activity AT fitzgeraldforrestg imitatingevolutionstinkeringbyproteinengineeringrevealsextensionofhumangalectin7activity AT garciacaballerogabriel imitatingevolutionstinkeringbyproteinengineeringrevealsextensionofhumangalectin7activity AT manningjoachimc imitatingevolutionstinkeringbyproteinengineeringrevealsextensionofhumangalectin7activity AT kriegsmannmark imitatingevolutionstinkeringbyproteinengineeringrevealsextensionofhumangalectin7activity AT kaltnerherbert imitatingevolutionstinkeringbyproteinengineeringrevealsextensionofhumangalectin7activity AT murphypaulv imitatingevolutionstinkeringbyproteinengineeringrevealsextensionofhumangalectin7activity AT cudicmare imitatingevolutionstinkeringbyproteinengineeringrevealsextensionofhumangalectin7activity AT kopitzjurgen imitatingevolutionstinkeringbyproteinengineeringrevealsextensionofhumangalectin7activity AT gabiushansjoachim imitatingevolutionstinkeringbyproteinengineeringrevealsextensionofhumangalectin7activity |